Singapore markets closed
Straits Times Index
3,166.27 -55.25 (-1.72%) Nikkei
28,751.62 -747.66 (-2.53%) Hang Seng
24,080.52 -659.64 (-2.67%) FTSE 100
7,044.03 -266.34 (-3.64%) BTC-USD
54,380.80 -539.21 (-0.98%) CMC Crypto 200
1,365.60 -89.82 (-6.17%)
Lyell Immunopharma, Inc. (LYEL)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
9.31-0.09 (-0.96%)
At close: 1:00PM EST
9.31 0.00 (0.00%)
After hours: 01:01PM EST
After hours: 01:01PM EST
Currency in USD
Valuation measures
| Market cap (intra-day) 5 | 2.25B |
| Enterprise value 3 | 1.70B |
| Trailing P/E | N/A |
| Forward P/E 1 | N/A |
| PEG Ratio (5 yr expected) 1 | N/A |
| Price/sales (ttm) | 221.34 |
| Price/book (mrq) | 2.28 |
| Enterprise value/revenue 3 | 167.41 |
| Enterprise value/EBITDA 7 | -8.65 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | -44.88% |
| S&P500 52-week change 3 | 26.87% |
| 52-week high 3 | 19.84 |
| 52-week low 3 | 8.93 |
| 50-day moving average 3 | 12.61 |
| 200-day moving average 3 | 14.28 |
Share statistics
| Avg vol (3-month) 3 | 470.1k |
| Avg vol (10-day) 3 | 332.75k |
| Shares outstanding 5 | 240.47M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 124.02M |
| % held by insiders 1 | 16.16% |
| % held by institutions 1 | 32.15% |
| Shares short (14 Nov 2021) 4 | 4.95M |
| Short ratio (14 Nov 2021) 4 | 21.82 |
| Short % of float (14 Nov 2021) 4 | 3.14% |
| Short % of shares outstanding (14 Nov 2021) 4 | 2.06% |
| Shares short (prior month 14 Oct 2021) 4 | 4.77M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sep 2021 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -2,082.35% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 10.14M |
| Revenue per share (ttm) | 0.13 |
| Quarterly revenue growth (yoy) | 157.50% |
| Gross profit (ttm) | 7.76M |
| EBITDA | -200.64M |
| Net income avi to common (ttm) | -205.37M |
| Diluted EPS (ttm) | -2.59 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 618.92M |
| Total cash per share (mrq) | 2.57 |
| Total debt (mrq) | 67.23M |
| Total debt/equity (mrq) | 6.82 |
| Current ratio (mrq) | 10.65 |
| Book value per share (mrq) | 4.11 |
Cash flow statement
| Operating cash flow (ttm) | -119.81M |
| Levered free cash flow (ttm) | N/A |
© 2021 Yahoo. All rights reserved.
